GAPDH (14C10) Rabbit Monoclonal Antibody…

The University of Nebraska Medical Center, a state institution operating under the Board of Regents of the University of Nebraska in Nebraska, awarded a purchase order to Cell Signaling Technology Inc., headquartered in Boston, Massachusetts, on May 20, 2026. The contract, valued at $157, covers the procurement of one unit of GAPDH (14C10) Rabbit Monoclonal Antibody (Material #2118T), a research-grade antibody reagent used in laboratory applications. The performance period spans from the award date of May 20, 2026, to the delivery deadline of May 26, 2026, with delivery directed to UNMC General Supply at 601 South Saddle Creek Road in Omaha, Nebraska.

The purchase order is structured under standard Net 30 payment terms with Free on Board Destination freight prepaid, with payment to be rendered by Nebraska State Treasury warrant. Cell Signaling Technology Inc. is required to acknowledge acceptance of the order within ten days and must reference the purchase order number on all packages, invoices, and related documentation. The contract is governed by the Standard Terms of Purchase established by the University of Nebraska unless superseded by a separate agreement between the vendor and the Board of Regents.